Related Experiment Video
Updated: Jan 14, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Ailanthone induces apoptosis in U-2OS cells through the endoplasmic reticulum stress
Yue Zhang1, Taiding Wu2, Chang Li1
1Department of Cardiology, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, Hubei, China.
Background:
Osteosarcoma (OS) is a malignant bone tumor that commonly occurs in children and adolescents, characterized by poor treatment outcomes and prognosis, highlighting the urgent need for alternative therapies. Endoplasmic reticulum stress (ERS) induces a series of cascade reactions known as the unfolded protein response (UPR), which is a crucial stress mechanism that cells utilize to cope with disrupted endoplasmic reticulum function and is widely involved in the apoptosis of tumor cells. Excessive UPR can lead to an overload of protein levels within cells, disrupting homeostasis and exhausting energy, ultimately inducing apoptosis in OS cells. Ailanthone (AIL), a natural compound derived from the root bark or stem bark of Ailanthus altissima (Mill.) Swingle, exhibits broad-spectrum anticancer activity across multiple tumor types. Its antitumor mechanism involves the modulation of endoplasmic reticulum stress (ERS)-associated proteins, including the upregulation of apoptotic markers (PERK, eIF2α, ATF4, CHOP) and pro-apoptotic factors (BAX, caspase-3, Bim), alongside the downregulation of the anti-apoptotic protein BCL-2. This study aims to investigate whether AIL induces apoptosis in OS cells via ERS.
Materials And Methods:
The effects of AIL (0-1.0 µmol/L) on the proliferation and migration of U-2OS cultured for 24 h were evaluated using the cell counting kit-8 assay and scratch wound healing assays. The optimal concentration of 0.6 µmol/L was selected for subsequent experiments. Western blot analysis was performed to measure the protein levels of ERS-related factors at different time points (0-24 h) following AIL treatment. Finally, the apoptosis rate of U-2OS cells after 24 h of culture at the optimal concentration was assessed by flow cytometry.
Results:
AIL exhibited a dose-and time-dependent inhibitory effect on U-2OS cell growth, significantly reducing cell proliferation and migration rates while promoting apoptosis. After AIL treatment, the levels of ERS-related proteins and pro-apoptotic proteins increased, while anti-apoptotic protein level decreased.
Conclusion:
AIL inhibited the proliferation of human OS cells and induced apoptosis through the ERS pathway. It represented a potential therapeutic agent for OS treatment.
Insights
Ailanthone (AIL) effectively inhibits osteosarcoma cell growth and migration by inducing apoptosis through the endoplasmic reticulum stress (ERS) pathway. This natural compound shows promise as a potential therapeutic agent for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Osteosarcoma (OS) is a prevalent bone cancer in children and adolescents with poor prognoses, necessitating novel therapeutic strategies.
- Endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) are critical cellular mechanisms involved in tumor cell apoptosis.
- Ailanthone (AIL), a natural compound, demonstrates anticancer properties by modulating ERS-related proteins.
Purpose of the Study:
- To investigate the potential of Ailanthone (AIL) in inducing apoptosis in osteosarcoma (OS) cells via the endoplasmic reticulum stress (ERS) pathway.
- To evaluate the effects of AIL on OS cell proliferation, migration, and apoptosis.
- To elucidate the molecular mechanisms underlying AIL's antitumor activity in OS.
Main Methods:
- Cell counting kit-8 and scratch wound healing assays were used to assess the effects of AIL on U-2OS cell proliferation and migration.
- Western blot analysis was employed to measure ERS-related and apoptosis-associated protein levels following AIL treatment.
- Flow cytometry was utilized to quantify the apoptosis rate in AIL-treated U-2OS cells.
Main Results:
- Ailanthone (AIL) demonstrated a dose- and time-dependent inhibition of U-2OS cell proliferation and migration.
- AIL treatment significantly increased apoptosis rates in osteosarcoma cells.
- Western blot analysis revealed increased levels of ERS-related proteins and pro-apoptotic factors, alongside decreased levels of anti-apoptotic proteins.
Conclusions:
- Ailanthone (AIL) effectively inhibits osteosarcoma cell proliferation and induces apoptosis through the endoplasmic reticulum stress (ERS) pathway.
- AIL exhibits potential as a therapeutic agent for osteosarcoma treatment.
- The findings support AIL's role in modulating ERS to achieve antitumor effects in osteosarcoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

